DR. SHARON E. SOULE, M.D.
Osteopathic Medicine at Arkansas St, Lawrence, KS
License number
Kansas 0430104
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
330 Arkansas St SUITE 105, Lawrence, KS 66044
Phone
(785) 840-2800
(785) 840-2813 (Fax)
(785) 840-2813 (Fax)
Personal information
See more information about SHARON E. SOULE at radaris.comName
Address
Phone
330 Arkansas St, Laurence, KS 66044
22010 53Rd St, Shawnee, KS 66226
Professional information
Dr. Sharon E Soule, Lawrence KS - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Lawrence Memorial Hosp ONC Ctr
330 Arkansas St SUITE 105, Lawrence 66044
(785) 505-2800 (Phone)
330 Arkansas St SUITE 105, Lawrence 66044
(785) 505-2800 (Phone)
Certifications:
Hematology, 2003, Internal Medicine, 1999, Medical Oncology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Lawrence Memorial Hosp ONC Ctr
330 Arkansas St SUITE 105, Lawrence 66044
Lawrence Memorial Hospital
325 Maine St, Lawrence 66044
330 Arkansas St SUITE 105, Lawrence 66044
Lawrence Memorial Hospital
325 Maine St, Lawrence 66044
Education:
Medical School
University of Kansas / School of Medicine
Graduated: 1996
University Of Iowa Hospitals & Clinics
Indiana U
University of Kansas / School of Medicine
Graduated: 1996
University Of Iowa Hospitals & Clinics
Indiana U
Sharon Elizabeth Soule, Laurence KS
Specialties:
Internal Medicine, Hematology & Oncology, Hematology, Medical Oncology
Work:
Lawrence Memorial Hospital
330 Arkansas St, Laurence, KS 66044
330 Arkansas St, Laurence, KS 66044
Education:
University of Kansas(1996)
Gene Expression Markers For Predicting Response To Chemotherapy
US Patent:
2005006, Mar 24, 2005
Filed:
May 24, 2004
Appl. No.:
10/852797
Inventors:
Joffre Baker - Montara CA, US
Kathy Miller - Zionville IN, US
Steven Shak - Hillsborough CA, US
George Sledge - Indianapolis IN, US
Sharon Soule - Lawrence KS, US
Kathy Miller - Zionville IN, US
Steven Shak - Hillsborough CA, US
George Sledge - Indianapolis IN, US
Sharon Soule - Lawrence KS, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
The invention provides sets of genes the expression of which predicts whether cancer patients are likely to have a beneficial treatment response to chemotherapy.